About VISX
VISX is a Healthcare company based in Milpitas (United States) founded in 1986, and was acquired by Abbott in November 2004. Laser technologies for refractive vision errors are developed and sold. Its chief executive, as recorded, is Elizabeth Davila. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Visx Inc. Its competitors include Clerio Vision, IntraLase and Lenticular Research Group; 3 of its 3 listed competitors have raised funding.
Company details
VISX was founded in 1986 in Milpitas, United States, within the medical device sector focused on ophthalmology. Laser systems addressing myopia, hyperopia, astigmatism, presbyopia, cataracts, spherical aberration, and corneal conditions are manufactured. The VISX STAR Excimer Laser System is employed for correcting nearsightedness, farsightedness, and astigmatism. Products are distributed through direct sales and international partners. Acquisition by Abbott occurred in 2005 for 1.4 billion.
Investors in VISX
VISX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for VISX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VISX
1 people are tracked at VISX (1 in leadership).
| Name | Role | Group |
|---|---|---|
Elizabeth Davila | President & CEO | Leadership |
Complete people profiles for VISX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VISX
2 dated milestones of VISX across 18 years, from founding to its latest funding, stage changes and deals.
- Founded VISX is founded.
- Exit Acquired by Abbott.
Competitors of VISX
VISX has 3 listed competitors in our database, 3 of them funded. They include Clerio Vision, IntraLase and Lenticular Research Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cleriovision.com | 2014 | Rochester, United States | $28.95M | 90 | Laser induced change in refractive index | |
| intralase.com | 1997 | Irvine, United States | $29.5M | Femtosecond laser technology is developed for eye surgery procedures. | ||
| lenticularresearchgroup.com | 2007 | Naperville, United States | $330,000 | Developer of laser device for treating the cause of presbyopia |
Detailed competitors of VISX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VISX
Websites that share an audience with VISX (visx.com).
Websites whose visitors overlap most with VISX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biosearch.com | 100% | View details | |||
teddy-tech.com | teddy-tech.com | 100% | – | ||
| arthrocare.com | 100% | View details | |||
eclmedical.com | eclmedical.com | 100% | – | ||
esquire.it | esquire.it | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for VISX
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as VISX (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VISX
VISX was founded in 1986.
VISX is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.
Elizabeth Davila is the CEO of VISX, as recorded in our data.
VISX was founded in 1986 in Milpitas, United States, within the medical device sector focused on ophthalmology. Laser systems addressing myopia, hyperopia, astigmatism, presbyopia, cataracts, spherical aberration, and corneal conditions are manufactured. The VISX STAR Excimer Laser System is employed for correcting nearsightedness, farsightedness, and astigmatism. Products are distributed through direct sales and international partners. Acquisition by Abbott occurred in 2005 for 1.4 billion.
VISX's top competitors include Clerio Vision, IntraLase and Lenticular Research Group.
VISX has 1 investor. Key investors include Abbott.
VISX operates through Visx Inc.
Yes. VISX was acquired by Abbott in November 2004.